GD
41
-4
MS
77
-2
PPG
57
-3
OXY
36
-2
UPS
48
2
SYF
86
-6
INTU
58
-3
T
48
3
AME
74
-4
WDC
37
-3
HAL
48
-3
XYL
35
-2
APH
65
-3
UAL
83
-2
HAS
30
-2
DOV
65
-4
MSI
72
-3
ETN
75
-3
CMG
66
-4
KO
38
-3
GD
41
-4
MS
77
-2
PPG
57
-3
OXY
36
-2
UPS
48
2
SYF
86
-6
INTU
58
-3
T
48
3
AME
74
-4
WDC
37
-3
HAL
48
-3
XYL
35
-2
APH
65
-3
UAL
83
-2
HAS
30
-2
DOV
65
-4
MSI
72
-3
ETN
75
-3
CMG
66
-4
KO
38
-3
Financhill
Back

iShares Currency Hdgd MSCI EAFE SmCp ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
47

HSCZ
iShares Currency Hdgd MSCI EAFE SmCp ETF

Last Price:
32.18
Seasonality Move:
-1.72%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
47
iShares Currency Hdgd MSCI EAFE SmCp ETF (HSCZ) is a Sell

Is iShares Currency Hdgd MSCI EAFE SmCp ETF a Buy, Sell or Hold?

  • The current iShares Currency Hdgd MSCI EAFE SmCp ETF [HSCZ] share price is $31.96. The Score for HSCZ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • HSCZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HSCZ Stock Price Chart

What is iShares Currency Hdgd MSCI EAFE SmCp ETF's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HSCZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 43.96 Sell
Chaikin Money Flow: -9421 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.02 - 32.52) Sell
Bollinger Bands (100): (31.29 - 32.59) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HSCZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.23 Sell
20-day SMA: 32.17 Sell
50-day SMA: 32.25 Sell
200-day SMA: 31.54 Buy
8-day EMA: 32.15 Sell
20-day EMA: 32.21 Sell
50-day EMA: 32.17 Sell
200-day EMA: 31.38 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares Currency Hdgd MSCI EAFE SmCp ETF Earnings Growth & HSCZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares Currency Hdgd MSCI EAFE SmCp ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):